Instituto Rosenbusch S.A.

BASE:ROSE Stock Report

Market Cap: AR$5.2b

Instituto Rosenbusch Past Earnings Performance

Past criteria checks 3/6

Instituto Rosenbusch has been growing earnings at an average annual rate of 55.2%, while the Pharmaceuticals industry saw earnings growing at 6.2% annually. Revenues have been growing at an average rate of 50.3% per year. Instituto Rosenbusch's return on equity is 22.1%, and it has net margins of 19.7%.

Key information

55.2%

Earnings growth rate

55.2%

EPS growth rate

Pharmaceuticals Industry Growth12.4%
Revenue growth rate50.3%
Return on equity22.1%
Net Margin19.7%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Instituto Rosenbusch makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BASE:ROSE Revenue, expenses and earnings (ARS Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 245,0811,0029550
31 Mar 245,1759991,0360
31 Dec 234,5285631,1560
30 Sep 236,721-2441,9040
30 Jun 236,787-5261,8170
31 Mar 235,138-1991,4220
31 Dec 224,276-251,0540
30 Sep 222,550596850
30 Jun 221,892195030
31 Mar 221,668294400
31 Dec 211,523-383970
30 Sep 211,266-562820
30 Jun 211,224-242550
31 Mar 211,009-382240
31 Dec 20843-261970
30 Sep 20746-472040
30 Jun 20662-632430
31 Mar 20585-1142090
31 Dec 19561-1212110
30 Sep 19360-1191320
30 Jun 19363-42810
31 Mar 19350-3910
31 Dec 182991790
30 Sep 18481-171390
30 Jun 18359-501210
31 Mar 18293-53980
31 Dec 17274-48900
30 Sep 1716311520
30 Jun 1717411560
31 Mar 1717111510
31 Dec 1616710460
30 Sep 161869510
30 Jun 161676480
31 Mar 161501440
31 Dec 15135-1390
30 Sep 15107-10300
30 Jun 15109-1290
31 Mar 15106-4290
31 Dec 141088280
30 Sep 141068260
30 Jun 14980250
31 Mar 14944240

Quality Earnings: ROSE has a large one-off gain of ARS315.3M impacting its last 12 months of financial results to 30th June, 2024.

Growing Profit Margin: ROSE became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ROSE has become profitable over the past 5 years, growing earnings by 55.2% per year.

Accelerating Growth: ROSE has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: ROSE has become profitable in the last year, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (8.3%).


Return on Equity

High ROE: ROSE's Return on Equity (22.1%) is considered high.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 21:26
End of Day Share Price 2025/01/02 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Instituto Rosenbusch S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution